Professor Tedder tabled a paper on the new generation Abbott and Ortho tests to be discussed at the ninth ACVSB meeting. Read more about Professor Tedder tabled a paper on the new generation Abbott and Ortho tests to be discussed at the ninth ACVSB meeting.
Dr Gunson wrote to regional transfusion directors enclosing an updated report on the comparison study of Abbott and Ortho anti-HCV test kits whilst noting that the study of the new generation tests was proceeding. Read more about Dr Gunson wrote to regional transfusion directors enclosing an updated report on the comparison study of Abbott and Ortho anti-HCV test kits whilst noting that the study of the new generation tests was proceeding.
Dr Gunson produced a paper reporting on the use of the RIBA II confirmatory assay to assess reactive results from the first-generation Ortho and Abbott study. Read more about Dr Gunson produced a paper reporting on the use of the RIBA II confirmatory assay to assess reactive results from the first-generation Ortho and Abbott study.
It was reported in "Blood Bank Week" that Chiron Corporation hoped to have their test to screen blood for non-A non-B Hepatitis available for clinical trials by the end of the year. Read more about It was reported in "Blood Bank Week" that Chiron Corporation hoped to have their test to screen blood for non-A non-B Hepatitis available for clinical trials by the end of the year.
In a minute to Scotland's Deputy Chief Medical Officer Dr Young, Dr McIntyre stated: "Things are moving very fast on the Hepatitis C front" and he anticipated that at the next Advisory Committee on the Virological Safety of Blood meeting it would be decided that "there is no alternative but to recommend the introduction of the test." Read more about In a minute to Scotland's Deputy Chief Medical Officer Dr Young, Dr McIntyre stated: "Things are moving very fast on the Hepatitis C front" and he anticipated that at the next Advisory Committee on the Virological Safety of Blood meeting it would be decided that "there is no alternative but to recommend the introduction of the test."
Dr Mortimer reported on developments in the pilot study, now comparing two further candidate screening tests, from Wellcome and UBI, with results from the Ortho and Abbott test kits. Read more about Dr Mortimer reported on developments in the pilot study, now comparing two further candidate screening tests, from Wellcome and UBI, with results from the Ortho and Abbott test kits.
Professor Cash noted that Dr Gunson conveyed his concern that the Department of Health had still not decided on a start date, and it now seemed the earliest possible date would be May or June 1991. Read more about Professor Cash noted that Dr Gunson conveyed his concern that the Department of Health had still not decided on a start date, and it now seemed the earliest possible date would be May or June 1991.
Professor Cash suggested that the evaluation of second-generation tests might be modified to accommodate the screening programme in Newcastle. Read more about Professor Cash suggested that the evaluation of second-generation tests might be modified to accommodate the screening programme in Newcastle.
Dr Gunson and Dr Perry had argued that there was already sufficient data for ACVSB to recommend to ministers the introduction of a first-generation Hepatitis C donation screening as soon as possible, but their views were rejected. Read more about Dr Gunson and Dr Perry had argued that there was already sufficient data for ACVSB to recommend to ministers the introduction of a first-generation Hepatitis C donation screening as soon as possible, but their views were rejected.
Professor Cash asked for "some idea of the current time schedule to the point of full marketing in the UK for full donation testing." Read more about Professor Cash asked for "some idea of the current time schedule to the point of full marketing in the UK for full donation testing."